Page 21 - midJersey Business - March 2015

established and advanced companies (for Abilify. While these low-cost drugs must medicinal companies worldwide are
example, J&J and Ortho-McNeil-Jans- pass FDA regulations, they have become located in the Central Jersey region.

sen). Some analysts have predicted that frequently used, especially during eco- These various industries have brought
there will be signiicant merger & acquisi- nomic struggles. Government healthcare in substantial revenue and employment

tion (M&A) activity in the years ahead.
reformation, the penetrability of foreign opportunities for people of the state. The
Typically, larger companies utilize markets, and the expanding usage of presence of J&J, Merck, Dr. Reddy’s, and

their wealth to acquire new products, generic drugs should provide an array
others has been encouraging to economic
diversify their services, and leverage on of conidence for Big Pharma industries development in the region.

the promising portfolios of smaller phar- moving forward.
Many notable pharmaceutical com-
maceutical organizations.3 This can have Pharmaceutical companies anticipate panies own record levels of available

broad implications on the stock market; signiicant international growth. The cash and are prepared to invest heavily
some of the most heavily traded stocks growth of developing markets, such
in their respective futures. At home and

are those of pharmaceutical companies. as India and China, and an increased abroad, there are numerous opportuni-
M&A activity, among other things, will responsiveness to international health ties for advancement.

undoubtedly alter the broad pharmaceu- crises are two prime reasons for this Healthcare reform should thoroughly
tical landscape. This will have consider- expectation. Bridgewater-based Sanoi
beneit the pharmaceutical industry and

able clout in the Central

Jersey region, where
many of the top-grossing
Nationally, the baby boomer generation,

medicine producers are
rising life expectancies, and the pervasiveness
located.

Expanding partner- of chronic diseases have cohesively expanded
ships and improving

operational eiciency the need for pharmaceutical products. Less
should allow New Jersey
expensive generic drugs are constantly intro-
pharmaceutical com-
panies to lourish and
duced as eficient alternatives to brand names.
remain prevalent for the
foreseeable future.

Accessibility to new
markets and diverse clientele will sees viable growth opportunities within augment the sale of medicine country-

broaden the elevated expectations of the Chinese markets.
wide. Expansion in emerging markets

industry.
Recently, the company has focused
and the development of new products
The pharmaceutical industry is likely on strategic advertising and expanding and services will be vital in ensuring the

to beneit from the Patient Protection their customer base in the country. Lo- future health and inancial wellness of
and Afordable Care Act. This decree will cal pharmaceutical companies remain pharmaceutical companies themselves.

expand medical coverage for millions
increasingly attentive to international As patents expire, more generic drugs are
of U.S. citizens and increase the avail- health crises, including various virus introduced, legislation is enacted, and

ability of medicine. Under the policy, outbreaks and the communicable disease the “race for the next blockbuster drug”
approximately 33 million more patients endemic across Sub-Saharan Africa.
ensues, the pharmaceutical industry will

will become properly insured, preventa- Many upper-tier pharmaceutical com- be worth paying profound attention to.
tive care options will expand, and the panies, especially from New Jersey, have

expense of medicine will no longer be a created charitable programs that have
signiicant roadblock.provided relief to disease-ravaged coun-
4
Nationally, the baby boomer genera- tries. While a cure for AIDS has not been SOURCES:
tion, rising life expectancies, and the discovered, research and development 1
Five Star Equities - www.marketwire.com/
press-release/record-levels-available-cash-
pervasiveness of chronic diseases have eforts will be ongoing in this regard. The
cohesively expanded the need for phar- presence of pharmaceutical companies moderate-r-d-development-will-see-big-phar-
ma-m-a-activity-nasdaq-achn-1743884.htm
maceutical products.
in these countries has been instrumental 2
Fitzsimmons – Pharmaceutical Industry
Less expensive generic drugs are con- in strengthening the names and reputa- Growth
stantly introduced as eicient alterna- tions of such corporations.
4
PRNewswire
5
tives to brand names such as Lipitor and
As mentioned before, some of the top
Business2community – Health and Wellness

march 2015
19